112 related articles for article (PubMed ID: 9609903)
1. Chronic thyroiditis: diffuse uptake of FDG at PET.
Yasuda S; Shohtsu A; Ide M; Takagi S; Takahashi W; Suzuki Y; Horiuchi M
Radiology; 1998 Jun; 207(3):775-8. PubMed ID: 9609903
[TBL] [Abstract][Full Text] [Related]
2. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
Kurata S; Ishibashi M; Hiromatsu Y; Kaida H; Miyake I; Uchida M; Hayabuchi N
Ann Nucl Med; 2007 Aug; 21(6):325-30. PubMed ID: 17705011
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with the development of new onset diffuse thyroid F18-fluorodeoxyglucose uptake after treatment of breast cancer in patients without a history of thyroid disease or thyroid dysfunction.
Kim SS; Kim SJ; Bae YT; Lee JY; Kim BH; Kim YK; Kim IJ
Thyroid; 2012 Jan; 22(1):53-8. PubMed ID: 22142373
[TBL] [Abstract][Full Text] [Related]
4. The significance of FDG uptake in bilateral thyroid glands.
Chen YK; Chen YL; Cheng RH; Yeh CL; Lee CC; Hsu CH
Nucl Med Commun; 2007 Feb; 28(2):117-22. PubMed ID: 17198352
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.
Karantanis D; Bogsrud TV; Wiseman GA; Mullan BP; Subramaniam RM; Nathan MA; Peller PJ; Bahn RS; Lowe VJ
J Nucl Med; 2007 Jun; 48(6):896-901. PubMed ID: 17504869
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of patterns of increased [
Tsubaki F; Kurata S; Tani J; Sumi A; Fujimoto K; Abe T
Jpn J Radiol; 2018 Mar; 36(3):181-193. PubMed ID: 29280068
[TBL] [Abstract][Full Text] [Related]
7. Pituitary 18F-FDG Uptake Correlates With Serum TSH Levels in Subjects With Diffuse Thyroid 18F-FDG Uptake.
Jeong YH; Kim D; Lee JW; Rhee Y; Nam KH; Yun M; Kim CK
Clin Nucl Med; 2015 Aug; 40(8):632-6. PubMed ID: 26018720
[TBL] [Abstract][Full Text] [Related]
8. Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland.
Wolf G; Aigner RM; Schaffler G; Schwarz T; Krippl P
Nucl Med Commun; 2003 Dec; 24(12):1225-30. PubMed ID: 14627848
[TBL] [Abstract][Full Text] [Related]
9. Detection of thyroiditis on PET/CT imaging: a systematic review.
Albano D; Treglia G; Giovanella L; Giubbini R; Bertagna F
Hormones (Athens); 2020 Sep; 19(3):341-349. PubMed ID: 32037486
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography.
Liu Y
Ann Nucl Med; 2009 Jan; 23(1):17-23. PubMed ID: 19205834
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of patterns of incidental thyroid uptake at (18)F-FDG PET/CT.
Agrawal K; Weaver J; Ngu R; Krishnamurthy Mohan H
Clin Radiol; 2015 May; 70(5):536-43. PubMed ID: 25687827
[TBL] [Abstract][Full Text] [Related]
12. Diffuse thyroid uptake incidentally found on 18F-fluorodeoxyglucose positron emission tomography in subjects without cancer history.
Lee JY; Choi JY; Choi YH; Hyun SH; Moon SH; Jang SJ; Choe YS; Lee KH; Kim BT
Korean J Radiol; 2013; 14(3):501-9. PubMed ID: 23690721
[TBL] [Abstract][Full Text] [Related]
13. Is 18F-FDG PET/CT useful for distinguishing between primary thyroid lymphoma and chronic thyroiditis?
Nakadate M; Yoshida K; Ishii A; Koizumi M; Tochigi N; Suzuki Y; Ryu Y; Nakagawa T; Umehara I; Shibuya H
Clin Nucl Med; 2013 Sep; 38(9):709-14. PubMed ID: 23816945
[TBL] [Abstract][Full Text] [Related]
14. Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism.
Rothman IN; Middleton L; Stack BC; Bartel T; Riggs AT; Bodenner DL
Eur Arch Otorhinolaryngol; 2011 Oct; 268(10):1501-4. PubMed ID: 21327732
[TBL] [Abstract][Full Text] [Related]
15. The frequency and spectrum of thymus 2-[fluorine-18] fluoro-2-deoxy-D-glucose uptake patterns in hyperthyroidism patients.
Chen YK; Yeh CL; Chen YL; Wang SC; Cheng RH; Kao PF
Acad Radiol; 2011 Oct; 18(10):1292-7. PubMed ID: 21893295
[TBL] [Abstract][Full Text] [Related]
16. Chronic thyroiditis in patients with advanced breast carcinoma: metabolic and morphologic changes on PET-CT.
Tateishi U; Gamez C; Dawood S; Yeung HW; Cristofanilli M; Inoue T; Macapinlac HA
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):894-902. PubMed ID: 19156410
[TBL] [Abstract][Full Text] [Related]
17. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging?
Hoegerle S; Juengling F; Otte A; Altehoefer C; Moser EA; Nitzsche EU
Radiology; 1998 Oct; 209(1):253-8. PubMed ID: 9769840
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
Uematsu H; Sadato N; Ohtsubo T; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Takahashi N; Yonekura Y; Tsuda G; Saito H; Hayashi N; Yamamoto K; Ishii Y
J Nucl Med; 1998 Mar; 39(3):453-9. PubMed ID: 9529291
[TBL] [Abstract][Full Text] [Related]
19. The significance of alteration 2-[fluorine-18]fluoro-2-deoxy-(D)-glucose uptake in the liver and skeletal muscles of patients with hyperthyroidism.
Chen YK; Chen YL; Tsui CC; Wang SC; Cheng RH
Acad Radiol; 2013 Oct; 20(10):1218-23. PubMed ID: 24029053
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
